INO-3107

INO-3107 · Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INO-3107, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) [Phase 1, Phase 2]

See pricing